IntrinsicIntrinsic
← All summaries

Archimedes Tech SPAC Partners II Co.

ATIIW
Financials & Chart →

Business Summary

Archimedes Tech SPAC Partners II Co. is a blank check company, or Special Purpose Acquisition Company (SPAC), incorporated in the Cayman Islands on June 7, 2024, with the sole purpose of effecting a business combination, such as a merger, share exchange, or asset acquisition, with one or more operating businesses . The company has not engaged in any operations or generated any revenue to date, classifying it as a "shell company" under the Securities Exchange Act of 1934 . Its primary business activity since its Initial Public Offering (IPO) has been identifying and evaluating suitable acquisition transaction candidates . The company intends to focus its search for businesses within the technology industry, specifically targeting the artificial intelligence, cloud services, and automotive technology sectors .

The company's core business model revolves around identifying and acquiring a target business within its specified focus areas. Revenue generation is not expected until after the completion of an initial business combination . Currently, the company generates non-operating income from interest earned on funds held in its trust account and bank account . The primary customer segments are not applicable as the company has no operations, but its "customers" in a sense are its public shareholders who invest in the SPAC with the expectation of a successful business combination. The company's strategy is to leverage its management team's industry knowledge, relationships, capital, and public vehicle to identify and complete a business combination, and then support the acquired business with industry relationships, insights, regulatory knowledge, financial expertise, and capital resources .

The company's product and service lines are not applicable as it is a blank check company with no business operations. Its strategic role is to serve as an acquisition vehicle.

For the fiscal year ended December 31, 2025, Archimedes Tech SPAC Partners II Co. reported a net income of $7,986,738 . This consisted of interest earned on cash held in the trust account of $8,710,969 and interest earned on cash in the bank account of $61,744 , offset by general and administrative expenses of $785,975 . The company had cash held in the trust account of $239,860,969 and cash outside the trust account of $1,362,766 as of December 31, 2025. Total liabilities amounted to $8,187,516 , which included a deferred underwriting fee payable of $8,050,000 . Ordinary shares subject to possible redemption were valued at $239,860,969 , representing 23,000,000 shares at a redemption value of $10.43 per share . The company's total shareholders' deficit was $(6,703,451) .

Comparing the fiscal year ended December 31, 2025, to the period from June 7, 2024 (inception) through December 31, 2024, the company transitioned from a net loss of $78,700 to a net income of $7,986,738 . This significant shift is primarily due to the generation of interest income from the trust account, which was established following the IPO on February 12, 2025 . General and administrative expenses increased from $78,700 in the inception period to $785,975 in 2025, reflecting the costs associated with being a public company and due diligence activities. Cash held in the trust account and cash in the bank account were $0 and $0 respectively as of December 31, 2024, compared to $239,860,969 and $1,362,766 as of December 31, 2025, following the IPO and private placement.

During the reported fiscal period, Archimedes Tech SPAC Partners II Co. consummated its Initial Public Offering on February 12, 2025, selling 23,000,000 units at $10.00 per unit, generating gross proceeds of $230,000,000 . Simultaneously, a private placement of 840,000 units occurred at $10.00 per unit, generating total proceeds of $8,400,000 . Following these transactions, $231,150,000 of net proceeds were placed in a trust account. The company also established three direct, wholly-owned subsidiaries in December 2025: ATII Merger Sub Inc., ATII Merger Sub II, LLC, and ATII Holdings Inc., formed to facilitate the consummation of a business combination .

Business Outlook

Archimedes Tech SPAC Partners II Co. has not provided specific revenue, margin, or EPS guidance for the upcoming period, as it is a blank check company with no operations and does not expect to generate operating revenues until after the completion of its initial business combination .

The primary growth area for the company is the successful completion of an initial business combination. The company intends to focus its search for businesses in the technology industry, with a specific emphasis on the artificial intelligence, cloud services, and automotive technology sectors . While the initial focus is on potential opportunities in the United States, the company may pursue international opportunities given the global nature of the technology industry . The management team plans to identify and contact potential target businesses, leveraging their collective experience in the technology industry and capital markets to complete a business combination and support the target business post-acquisition . The company believes its competitive strengths, including experience recognizing key technology trends, identifying strong management teams, operating experience, deep network and connections to company founders, and prior SPAC experience, position it well to find and attract an exciting technology business .

The company's operational outlook is centered on managing its existing capital to facilitate a business combination. It incurs expenses as a public company for legal, financial reporting, accounting, and auditing compliance, as well as for due diligence expenses . The company has an agreement to pay its sponsor a monthly fee of $10,000 for office space, administrative, and support services, which will cease upon completion of the initial business combination or liquidation . The underwriters are also entitled to a deferred fee of $8,050,000 , payable from the trust account solely upon the completion of an initial business combination .

Regarding planned capital allocation, the company intends to use substantially all of the funds held in the trust account, including any interest earned (less income taxes payable), to complete its initial business combination . If share capital or debt is used as consideration, the remaining proceeds in the trust account will be used as working capital to finance the operations of the target business, make other acquisitions, and pursue growth strategies . Funds held outside the trust account, which amounted to $1,362,766 as of December 31, 2025, are intended to be used primarily to identify and evaluate target businesses, perform due diligence, cover travel expenses, review corporate documents, and structure, negotiate, and complete an initial business combination . The sponsor, officers, or directors may loan the company up to $1,500,000 for working capital deficiencies or transaction costs, convertible into units at $10.00 per unit at the lender's option, if a business combination is completed .

The company faces a structural headwind in that it must complete an initial business combination by November 12, 2026 . Failure to do so will result in the company ceasing all operations except for winding up, redeeming public shares, and liquidating . This mandatory liquidation date raises substantial doubt about the company's ability to continue as a going concern . Management plans to consummate an initial business combination prior to this date . Geopolitical instability, such as military conflicts in Ukraine and the Middle East, and broader macroeconomic factors like changes in laws or regulations, downturns in financial markets, inflation, fluctuations in interest rates, increases in tariffs, supply chain disruptions, and declines in consumer confidence and spending, could adversely affect the company's search for a business combination .

Risk Factors

The most material risks disclosed in the filing relate to the company's status as a blank check company. The primary risk is the inability to complete an initial business combination by November 12, 2026 , which would lead to the company ceasing operations, redeeming public shares at a per-share price equal to the aggregate amount then on deposit in the trust account (net of taxes and up to $100,000 for dissolution expenses), and liquidating, resulting in the warrants expiring worthless . This mandatory liquidation date raises substantial doubt about the company's ability to continue as a going concern . Macroeconomic and geopolitical factors, including changes in laws or regulations, financial market downturns, inflation, interest rate fluctuations, tariffs, supply chain disruptions, declines in consumer confidence, public health considerations, and military conflicts (e.g., Ukraine and the Middle East), could adversely affect the search for a target business . The company also faces intense competition from other entities with similar business objectives, including private investors and other blank check companies, many of whom possess greater technical, human, and financial resources . Conflicts of interest may arise as the company's initial shareholders and management team may have fiduciary, contractual, or other obligations to other entities, potentially requiring them to present business combination opportunities to those entities first . Furthermore, the sponsor's indemnification obligations for claims against the trust account are limited, and there is no independent verification of the sponsor's ability to satisfy these obligations, as its only assets are securities of the company .

Management Priorities

Management's overall tone emphasizes the company's strategic focus on identifying and completing an initial business combination within the technology industry, specifically targeting artificial intelligence, cloud services, and automotive technology sectors. They highlight the management team's deep operational and product experience, extensive networks, and track records as investors, advisors, and board members as competitive strengths to attract and support a target business. The key strategic priorities for the period ahead are to diligently identify and evaluate suitable acquisition candidates, leverage the team's expertise and network to create proprietary transaction opportunities, and successfully consummate an initial business combination by November 12, 2026 . Management explicitly states their plan to use substantially all funds in the trust account, including interest earned (less income taxes payable), to complete the initial business combination . They also acknowledge the significant costs incurred in the pursuit of acquisition plans and the inherent uncertainty of successfully completing a business combination .

View Source Annual Report on SEC.gov ↗

References

  1. [1] Item 1, Business — Introduction
  2. [2] Item 1, Business — Introduction
  3. [3] Item 1C, Cybersecurity
  4. [4] Item 1, Business — Effecting Our Initial Business Combination
  5. [5] Item 7, MD&A — Results of Operations
  6. [6] Item 7, MD&A — Results of Operations
  7. [7] Item 1, Business — Business Strategy
  8. [8] Item 7, MD&A — Results of Operations
  9. [9] Item 7, MD&A — Results of Operations
  10. [10] Item 7, MD&A — Results of Operations
  11. [11] Item 7, MD&A — Results of Operations
  12. [12] Item 7, MD&A — Liquidity and Capital Resources
  13. [13] Item 7, MD&A — Liquidity and Capital Resources
  14. [14] Item 8, Consolidated Balance Sheets
  15. [15] Item 7, MD&A — Contractual Obligations
  16. [16] Item 8, Consolidated Balance Sheets
  17. [17] Item 8, Consolidated Balance Sheets
  18. [18] Item 8, Consolidated Balance Sheets
  19. [19] Item 7, MD&A — Results of Operations
  20. [20] Item 7, MD&A — Results of Operations
  21. [21] Item 7, MD&A — Results of Operations
  22. [22] Item 7, MD&A — Results of Operations
  23. [23] Item 7, MD&A — Results of Operations
  24. [24] Item 8, Consolidated Balance Sheets
  25. [25] Item 8, Consolidated Balance Sheets
  26. [26] Item 8, Consolidated Balance Sheets
  27. [27] Item 8, Consolidated Balance Sheets
  28. [28] Item 1, Business — Introduction
  29. [29] Item 1, Business — Introduction
  30. [30] Item 1, Business — Introduction
  31. [31] Item 7, MD&A — Overview
  32. [32] Item 7, MD&A — Results of Operations
  33. [33] Item 1, Business — Effecting Our Initial Business Combination
  34. [34] Item 1, Business — Business Strategy
  35. [35] Item 1, Business — Business Strategy
  36. [36] Item 1, Business — Competitive Strengths
  37. [37] Item 7, MD&A — Results of Operations
  38. [38] Item 7, MD&A — Contractual Obligations
  39. [39] Item 7, MD&A — Contractual Obligations
  40. [40] Item 7, MD&A — Contractual Obligations
  41. [41] Item 7, MD&A — Contractual Obligations
  42. [42] Item 7, MD&A — Liquidity and Capital Resources
  43. [43] Item 7, MD&A — Liquidity and Capital Resources
  44. [44] Item 7, MD&A — Liquidity and Capital Resources
  45. [45] Item 7, MD&A — Liquidity and Capital Resources
  46. [46] Item 7, MD&A — Liquidity and Capital Resources
  47. [47] Item 7, MD&A — Liquidity and Capital Resources
  48. [48] Item 7, MD&A — Liquidity and Capital Resources
  49. [49] Item 7, MD&A — Liquidity and Capital Resources
  50. [50] Item 1, Business — Initial Business Combination
  51. [51] Item 7, MD&A — Liquidity and Capital Resources
  52. [52] Item 7, MD&A — Liquidity and Capital Resources
  53. [53] Item 6, Commitments and Contingencies — Risks and Uncertainties
  54. [54] Item 7, MD&A — Liquidity and Capital Resources
  55. [55] Item 1, Business — Initial Business Combination
  56. [56] Item 1, Business — Redemption of Public Shares and Liquidation if No Initial Business Combination
  57. [57] Item 7, MD&A — Liquidity and Capital Resources
  58. [58] Item 6, Commitments and Contingencies — Risks and Uncertainties
  59. [59] Item 1, Business — Competition
  60. [60] Item 1, Business — Our Acquisition Process
  61. [61] Item 1, Business — Redemption of Public Shares and Liquidation if No Initial Business Combination
  62. [62] Item 7, MD&A — Liquidity and Capital Resources
  63. [63] Item 7, MD&A — Liquidity and Capital Resources
  64. [64] Item 7, MD&A — Overview

Analysis on 5/22/2026